AAAAAA

   
Results: 1-25 | 26-40 |
Results: 26-40/40
Prediction of dopamine transporter binding availability by genotype: A preliminary report
Authors: Jacobsen, LK Staley, JK Zoghbi, S Seibyl, JP Kosten, TR Innis, RB Gelernter, J
Citation: Lk. Jacobsen et al., Prediction of dopamine transporter binding availability by genotype: A preliminary report, AM J PSYCHI, 157(10), 2000, pp. 1700-1703
Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [F-18]altanserin in human and rodent
Authors: Tan, PZ Baldwin, RM Van Dyck, CH Al-Tikriti, M Roth, B Khan, N Charney, DS Innis, RB
Citation: Pz. Tan et al., Characterization of radioactive metabolites of 5-HT2A receptor PET ligand [F-18]altanserin in human and rodent, NUCL MED BI, 26(6), 1999, pp. 601-608
A complete remote-control system for reliable preparation of [F-18]altanserin
Authors: Tan, PZ Baldwin, RM Soufer, R Garg, PK Charney, DS Innis, RB
Citation: Pz. Tan et al., A complete remote-control system for reliable preparation of [F-18]altanserin, APPL RAD IS, 50(5), 1999, pp. 923-927
[I-123]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia
Authors: Verhoeff, NPLG Soares, JC D'Souza, CD Gil, R Degen, K Abi-Dargham, A Zoghbi, SS Fujita, M Rajeevan, N Seibyl, JP Krystal, JH van Dyck, CH Charney, DS Innis, RB
Citation: Nplg. Verhoeff et al., [I-123]Iomazenil SPECT benzodiazepine receptor imaging in schizophrenia, PSYCH RES-N, 91(3), 1999, pp. 163-173
Quantitation of benzodiazepine receptor binding with PET [C-11]iomazenil and SPECT [I-123]iomazenil: preliminary results of a direct comparison in healthy human subjects
Authors: Bremner, JD Baldwin, R Horti, A Staib, LH Ng, CK Tan, PZ Zea-Ponce, Y Zoghbi, S Seibyl, JP Soufer, R Charney, DS Innis, RB
Citation: Jd. Bremner et al., Quantitation of benzodiazepine receptor binding with PET [C-11]iomazenil and SPECT [I-123]iomazenil: preliminary results of a direct comparison in healthy human subjects, PSYCH RES-N, 91(2), 1999, pp. 79-91
No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia
Authors: Abi-Dargham, A Laruelle, M Krystal, J D'Souza, C Zoghbi, S Baldwin, RM Seibyl, J Mawlawi, O de Erasquin, G Charney, D Innis, RB
Citation: A. Abi-dargham et al., No evidence of altered in vivo benzodiazepine receptor binding in schizophrenia, NEUROPSYCH, 20(6), 1999, pp. 650-661
Kinetic and equilibrium analyses of [I-123]epidepride binding to striatal and extrastriatal dopamine D-2 receptors
Authors: Fujita, M Seibyl, JP Verhoeff, NPLG Ichise, M Baldwin, RM Zoghbi, SS Burger, C Staley, JK Rajeevan, N Charney, DS Innis, RB
Citation: M. Fujita et al., Kinetic and equilibrium analyses of [I-123]epidepride binding to striatal and extrastriatal dopamine D-2 receptors, SYNAPSE, 34(4), 1999, pp. 290-304
Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [I-123]beta-CIT
Authors: Innis, RB Marek, KL Sheff, K Zoghbi, S Castronuovo, J Feigin, A Seibyl, JP
Citation: Rb. Innis et al., Effect of treatment with L-dopa/carbidopa or L-selegiline on striatal dopamine transporter SPECT imaging with [I-123]beta-CIT, MOVEMENT D, 14(3), 1999, pp. 436-442
Rapid synthesis of F-18 and H-2 dual-labeled altanserin, a metabolically resistant PET ligand for 5-HT2A receptors
Authors: Tan, PZ Baldwin, RM Fu, T Charney, DS Innis, RB
Citation: Pz. Tan et al., Rapid synthesis of F-18 and H-2 dual-labeled altanserin, a metabolically resistant PET ligand for 5-HT2A receptors, J LABEL C R, 42(5), 1999, pp. 457-467
Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D-2 receptor binding with [I-123]epidepride SPECT
Authors: Ichise, M Fujita, M Seibyl, JP Verhoeff, NPLG Baldwin, RM Zoghbi, SS Rajeevan, N Charney, DS Innis, RB
Citation: M. Ichise et al., Graphical analysis and simplified quantification of striatal and extrastriatal dopamine D-2 receptor binding with [I-123]epidepride SPECT, J NUCL MED, 40(11), 1999, pp. 1902-1912
Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans
Authors: Fujita, M Woods, SW Verhoeff, NPLG Abi-Dargham, A Baldwin, RM Zoghbi, SS Soares, JC Jatlow, PA Krystal, JH Rajeevan, N Charney, DS Seibyl, JP Innis, RB
Citation: M. Fujita et al., Changes of benzodiazepine receptors during chronic benzodiazepine administration in humans, EUR J PHARM, 368(2-3), 1999, pp. 161-172
Effects of vigabatrin on the GABAergic system as determined by [I-123]iomazenil SPECT and GABA MRS
Authors: Verhoeff, NPLG Petroff, OAC Hyder, F Zoghbi, SS Fujita, M Rajeevan, N Rothman, DL Seibyl, JP Mattson, RH Innis, RB
Citation: Nplg. Verhoeff et al., Effects of vigabatrin on the GABAergic system as determined by [I-123]iomazenil SPECT and GABA MRS, EPILEPSIA, 40(10), 1999, pp. 1433-1438
New requirements for manuscripts submitted to Biological Psychiatry: Informed consent and protection of subjects
Authors: Charney, DS Innis, RB Nestler, EJ
Citation: Ds. Charney et al., New requirements for manuscripts submitted to Biological Psychiatry: Informed consent and protection of subjects, BIOL PSYCHI, 46(8), 1999, pp. 1007-1008
Neurochemical brain imaging investigations of schizophrenia
Authors: Soares, JC Innis, RB
Citation: Jc. Soares et Rb. Innis, Neurochemical brain imaging investigations of schizophrenia, BIOL PSYCHI, 46(5), 1999, pp. 600-615
Increasing public trust and confidence in psychiatric research
Authors: Charney, DS Innis, RB Nestler, EJ Davis, KL Nemeroff, CB Weinberger, DR
Citation: Ds. Charney et al., Increasing public trust and confidence in psychiatric research, BIOL PSYCHI, 46(1), 1999, pp. 1-2
Risultati: 1-25 | 26-40 |